Payden & Rygel Bristol Myers Squibb CO Transaction History

Payden & Rygel

$1.24 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Oct 07, 2024	SELL	$40.25 - $52.99 $152,950 - $201,362	-3,800 Closed	0 $0
Q1 2024 Oct 08, 2024	BUY	$47.98 - $54.4 $182,324 - $206,720	3,800 New	3,800 $206,000
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $13 Million - $14.4 Million	-203,940 Reduced 98.17%	3,800 $243,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $15.5 Million - $17.5 Million	-235,320 Reduced 53.11%	207,740 $14.4 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $287,616 - $340,578	-4,200 Reduced 0.94%	443,060 $31.9 Million
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $10,114 - $5.98 Million	77,800 Added 21.06%	447,260 $31.8 Million
Q1 2022 Apr 13, 2022	SELL	$61.48 - $73.72 $21.7 Million - $26 Million	-352,500 Reduced 48.83%	369,460 $27 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $311,054 - $362,616	5,800 Added 0.81%	721,960 $45 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $22 Million - $25.7 Million	371,460 Added 107.76%	716,160 $42.4 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $7.65 Million - $8.33 Million	-123,600 Reduced 26.39%	344,700 $23 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $551,862 - $620,682	9,300 Added 2.03%	468,300 $29.6 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $369,536 - $418,752	-6,400 Reduced 1.38%	459,000 $28.5 Million
Q3 2020 Nov 10, 2020	SELL	$57.43 - $63.64 $5.86 Million - $6.49 Million	-102,000 Reduced 17.98%	465,400 $28.1 Million
Q2 2020 Aug 12, 2020	SELL	$54.82 - $64.09 $389,222 - $455,039	-7,100 Reduced 1.24%	567,400 $33.4 Million
Q1 2020 May 04, 2020	BUY	$46.4 - $67.43 $1.88 Million - $2.73 Million	40,508 Added 7.59%	574,500 $32 Million
Q4 2019 Jan 31, 2020	BUY	$49.21 - $64.19 $10.7 Million - $13.9 Million	217,000 Added 68.46%	533,992 $34.3 Million
Q3 2019 Oct 30, 2019	BUY	$42.77 - $50.71 $13.6 Million - $16.1 Million	316,992 New	316,992 $16.1 Million

Others Institutions Holding BMY

# of Institutions

2,425

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.93 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.87 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Payden & Rygel, based on Form 13F filings with the SEC.

News

Stay updated on Payden & Rygel with notifications on news.

Account